Ruxience

List of products in the National Drug Code with proprietary name ruxience. Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells. Some brands of rituximab are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. This drug is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions. This monograph is about the following rituximab products: rituximab, rituximab-abbs, and rituximab-pvvr.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0069-0238Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-0249Ruxience Rituximab-pvvrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncHuman Prescription Drug